Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 2p13 2 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental course | Features vary by deleted genes; a specific pattern is not established. | Developmental delay may occur, but severity and domains vary. | Low |
| Age at recognition | Supplied onset is at birth, though presentation can still vary. | Supplied onset spans birth through early childhood. | Moderate |
| Overall clinical burden | Source severity is severe, but individual findings are not defined. | Source severity is moderate, with supportive care emphasized. | Moderate |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A chromosomal microarray shows a 2p13.2 deletion.
The genomic location and loss of material distinguish it from a 14q11.2 gain.
High
Findings are present from birth and clinically substantial.
This fits the supplied congenital, severe profile, but gene content still matters.
Moderate
Counseling concerns inheritance of a deletion.
Parental studies may clarify whether the deletion is de novo or inherited.
Moderate
Choose 14q11 2 Microduplication Syndrome C4749855 when
Testing shows extra material at 14q11.2.
A duplication at this locus is the defining laboratory distinction.
High
Concerns emerge between birth and age five.
The supplied onset range is broader than the left condition.
Moderate
Developmental delay is the main reported feature.
Delay is mentioned for the right condition, but it is not specific.
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss involving 2p13.2. | Copy-number gain involving 14q11.2. | The chromosome, band, and loss versus gain distinguish the findings. |
| Parental chromosomal studies | May show inherited or de novo deletion; result not predictable here. | May show inherited or de novo duplication; result not predictable here. | Parental testing informs recurrence counseling but does not define severity. |
| Developmental assessment | No uniform deficit pattern is established. | Delay may be identified, with variable domains and severity. | Assessment guides support; it cannot replace genomic confirmation. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established and may vary with gene content and associated findings.
- Factors
- Deleted genes, congenital anomalies, developmental needs, and available supports.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Outcome is variable; developmental delay may occur, but a uniform course is not established.
- Factors
- Duplicated genes, developmental profile, associated findings, and supportive services.
Time frame: Lifelong, with needs potentially changing from infancy through childhood and beyond.
Exact prognosis, mortality, and prevalence should not be inferred from these sparse source data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible but not specifically established by the supplied data. Developmental delay is a reported possible feature. Needs individualized developmental surveillance. |
| Medical complexity | Labeled severe, although exact complications are not listed. Labeled moderate, with monitoring and supportive care described. Severity labels should not be treated as individual prognoses. |
| Recurrence in a family | Depends on parental results and rearrangement type. Depends on parental results and rearrangement type. Genetic counseling is appropriate for both. |
Patient education highlights
- HighWhat the result means
A copy-number finding is not the same as a complete prediction of symptoms; a clinician should interpret it with the full evaluation.
- HighCare approach
Care is individualized and supportive. No specific medicine, dose, or uniform treatment is established here.
- MediumFamily planning
Ask about parental testing and recurrence counseling; inheritance cannot be assumed from the child result alone.